EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease

K K Petersen, A Ezzati, R B Lipton, B A Gordon, J Hassenstab, J C Morris, E Grober

The Journal of Prevention of Alzheimer's Disease · 2023

DOI: 10.14283/jpad.2022.98 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Prevention of Alzheimer's Disease, 2023. Verfasst von K K Petersen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kellen K. Petersen, Albert Einstein College of Medicine, 1225 Morris Park Avenue, Bronx, NY 10461, USA, kellen.petersen@einsteinmed.edu. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, FDA HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate cerebrospinal fluid (CSF) and neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) based on Free and Cued Selective Reminding Test (FCSRT) performance, and to evaluate the effect of APOE ε4 status on this relationship. METHODS: Data from 586 cognitively unimpaired individuals who had FCSRT, CSF, and volumetric magnetic resonance imaging (MRI) measures available was used. We compared CSF measures of β-amyloid (Aβ42/Aβ40 ratio), phosphorylated tau (p-Tau181), total tau (t-Tau), hippocampal volume, and PIB-PET mean cortical binding potential with partial volume correction (MCBP) among SOMI groups in the whole sample and in subsamples stratified by APOE ε4 status. RESULTS: Participants had a mean age of 67.4 (SD=9.1) years, had 16.1 (SD=2.6) years of education, 57.0% were female, and 33.8% were APOE ε4 positive. In the entire sample, there was no significant difference between SOMI stages in Aβ42/Aβ40 ratio, p-Tau181, t-Tau, or PIB-PET MCBP when adjusted for age, sex, and education. However, higher SOMI stages had smaller hippocampal volume (F=3.29, p=0.020). In the stratified sample based on APOE ε4 status, in APOE ε4 positive individuals, higher SOMI stages had higher p-Tau181 (F=2.94, p=0.034) higher t-Tau (F=3.41, p=0.019), and smaller hippocampal volume (F=5.78, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAgedFemaleHumansMaleAmyloid beta-PeptidesApolipoprotein E4BiomarkersNeuroimagingMiddle Aged

Stichwörter der Autor:innen

APOE ε4SOMIbiomarkerscerebrospinal fluidcognition

Substanzen

Amyloid beta-PeptidesApolipoprotein E4Biomarkers

Autor:innen und Institutionen

  • Kellen K. Petersen, Albert Einstein College of Medicine, 1225 Morris Park Avenue, Bronx, NY 10461, USA, kellen.petersen@einsteinmed.edu.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • FDA HHS

Zitieren

APA

Petersen, K. K., Ezzati, A., Lipton, R. B., Gordon, B. A., Hassenstab, J., Morris, J. C., & Grober, E. (2023). Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.14283/jpad.2022.98

Vancouver

Petersen KK, Ezzati A, Lipton RB, Gordon BA, Hassenstab J, Morris JC, et al. Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease. The Journal of Prevention of Alzheimer's Disease. 2023. doi:10.14283/jpad.2022.98

BibTeX
@article{Petersen2023,
  author = {Petersen, K K and Ezzati, A and Lipton, R B and Gordon, B A and Hassenstab, J and Morris, J C and Grober, E},
  title = {Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  year = {2023},
  doi = {10.14283/jpad.2022.98}
}
Kostenlos starten →